Archetype MedTech’s Post

Market assessment provides crucial insights into customer needs, competitive forces, and potential barriers to entry. Equally critical are regulatory requirements, which vary across countries and regions. Compliance with stringent standards ensures patient safety and product efficacy, but it can also be a complex and time-consuming process. Work with us: ✅Know your market before you launch. Our technical expertise provides a realistic evaluation of your product's potential for market approval. ✅ Investor-ready? We provide comprehensive reports that highlight your product's strengths, address potential concerns, and build investor confidence. ✅Don't gamble on market approval. Make informed decisions based on our expert assessment of your product's readiness. Get in touch: https://loom.ly/dUbmGew #Medtech #innovation #medicaldevices

If you want an information architect's perspective on how to use information architecture to improve strategy and design, read this case study by The Understanding Group (TUG).

At the Surgical Disruptive Technology Summit, The Mullings Group's Joe Mullings sat down with Proximie's CEO and Founder, Dr. Nadine Hachach-Haram FRCS (Plast), BEM and Greg Roche of Distalmotion, to discuss the critical need for trusted collaborations in the medtech industry. In this wide-ranging discussion about the principles behind Proximie's partnership with Distalmotion, the trio highlighted the following: 🤝 The reciprocity of a partnership that brings together shared learnings and expertise, that ultimately get channelled towards delivering the best patient care possible. A partnership based on an "Invent together" ethos. ⚡ The "great fit" of Proximie and Distalmotion's partnership. "Otherwise I'm hiring 50 software engineers and we're having to build the piping and infrastructure that Proximie provide. It would take us years to do that instead of days." 🌐 How the partnership enables connectivity that "literally breaks down barriers." 💡 Proximie's role as "the digital powerhouse" that can help drive great and elegant robots like Distalmotion forwards on their journey. To watch the full interview, click on the link below. #medtech #collaboration #robotics #software #cloudcomputing

Next week! 📣 We're talking about RIM maturity on December 3 at 12 PM ET, and we have an expert panel lined up to share their insights: 🔹Steve Gens MSOD, Managing Partner - Gens & Associates 🔹Brian Williams, Managing Director, Life Science Operations Consulting - KPMG 🔹Adrienne Bishop, Director of Global Regulatory Affairs - Boston Scientific 🔹James Gianoutsos, MBA, Founder and CEO - Rimsys 📆 Save your seat as we look at the various levels of RIM maturity, provide practical guidance to help you modernize your regulatory information management strategy, and discuss AI's role in MedTech digitization: https://hubs.li/Q02ZyMs90.

Join me with Christine Senn from Advarra as we discuss the power of moving from siloed processes to integrated collaboration between sponsors, CROs, and sites. Christine shares how this approach is driving results in research — accelerating timelines, reducing costs, and ultimately improving patient access to trials. Join us to dive into the challenges of study startup and the risks posed by working in isolation ⇢ https://lnkd.in/ggS_98cP

𝐃𝐫𝐮𝐠 𝐝𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐢𝐬 𝐧𝐨𝐭 𝐚 𝐬𝐨𝐥𝐨 𝐦𝐢𝐬𝐬𝐢𝐨𝐧 🚀   In the high-stakes world of life sciences, innovation is booming, but so are the challenges. As the pace of R&D accelerates, navigating the complex path from concept to clinical success often requires more than just a great idea—it demands a strategic, expert-driven approach. At 2 Bridge, we believe that overcoming these hurdles is not a one-person job. It’s a mission that calls for a 𝐓𝐢𝐠𝐞𝐫 𝐓𝐞𝐚𝐦.   In our upcoming blog series, we’ll demonstrate how 2 Bridge 𝐓𝐢𝐠𝐞𝐫 𝐓𝐞𝐚𝐦 approach can transform your compound development journey. We’ll introduce you to the key players behind this strategy and share some compelling case studies that highlight our impact on both early-phase projects and later-stage submissions - illustrating how our collaborative efforts have helped bring science to life.   💡Curious to learn how we take life sciences to new heights? 👇Dive into our latest blog and stay tuned for more! #crossfuntionalteam #drugdevelopment #lifescience

Investing in a landscape assessment is like buying an insurance policy for your business strategy.

The life sciences ecosystem is undergoing a pivotal transformation, fuelled by a new wave of startups that are redefining the scaling process. Based on our extensive experience working with other biotech startups, we've observed that many face common challenges when trying to break away from traditional norms. That's why we offer this solution: leveraging an innovative tiger team strategy—a flexible and agile approach designed to tackle the complex hurdles that these companies often encounter as they navigate this dynamic industry landscape.

🔍 The Future of Clinical Research: Fast, Easy, and Personalized Access to Data In today’s rapidly evolving healthcare landscape, speed and precision are everything. Yet, accessing detailed information about relevant clinical trials and using it to create new protocols can still be a painstaking process for many researchers. It’s time to change that. Imagine a world where personalized, real-time access to clinical trial data is the norm. A world where you can instantly find the most relevant trials, dive deep into the details, and use that information to rapidly create new, tailored protocols. At TrialsSphere, we’re making that vision a reality: 🔹 Fast, Intuitive Search: Our GenAI-powered platform delivers personalized results, prioritizing the data most relevant to your needs. 🔹 Seamless Data Integration: Access detailed information from public and private sources in one place. 🔹 Effortless Protocol Creation: Turn data insights into actionable plans with tools designed to draft new trials in record time. 🔹 Precision at Scale: Whether you’re focused on niche studies or large-scale trials, TrialsSphere adapts to your unique requirements. Clinical research is moving beyond just finding the data. It’s about using that data to transform possibilities into realities. The future belongs to those who can harness information with speed and precision—and we’re here to help you do exactly that. 🔗 Discover how at TrialsSphere.com #ClinicalTrials #ThoughtLeadership #GenAI #HealthcareTransformation #ResearchInnovation #PrecisionMedicine #TrialsSphere

VeriSIM Life is excited to be part of Digital Medicine Society (DiMe)'s Building Business Case for Digital Endpoints project! To make sure we’re not just talking into the void, we launched an industry benchmarking survey to uncover the mysteries of digital endpoints—what makes them valuable, what hurdles they face, and how we can measure their success (without the crystal ball). If you're in the clinical trials space and consider yourself an SME (or know someone who does), we’d be eternally grateful if you could spare a few minutes to fill it out. Think of it as your good deed of the day—and who knows, you might just help shape the future of clinical trials! https://lnkd.in/e3QNDUyi